{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:34:02Z","timestamp":1785155642176,"version":"3.55.0"},"reference-count":100,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["APVV-18-0088"],"award-info":[{"award-number":["APVV-18-0088"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["vvgs-pf-2022-2116"],"award-info":[{"award-number":["vvgs-pf-2022-2116"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Operational Programme Integrated Infrastructure","award":["APVV-18-0088"],"award-info":[{"award-number":["APVV-18-0088"]}]},{"name":"Operational Programme Integrated Infrastructure","award":["vvgs-pf-2022-2116"],"award-info":[{"award-number":["vvgs-pf-2022-2116"]}]},{"name":"ERDF and Internal Scientific Grants System (VVGS) of Faculty of Science UPJ\u0160","award":["APVV-18-0088"],"award-info":[{"award-number":["APVV-18-0088"]}]},{"name":"ERDF and Internal Scientific Grants System (VVGS) of Faculty of Science UPJ\u0160","award":["vvgs-pf-2022-2116"],"award-info":[{"award-number":["vvgs-pf-2022-2116"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Deregulation of signalling pathways that regulate cell growth, survival, metabolism, and migration can frequently lead to the progression of cancer. Brain tumours are a large group of malignancies characterised by inter- and intratumoral heterogeneity, with glioblastoma (GBM) being the most aggressive and fatal. The present study aimed to characterise the expression of cancer pathway-related genes (n = 84) in glial tumour cell lines (A172, SW1088, and T98G). The transcriptomic data obtained by the qRT-PCR method were compared to different control groups, and the most appropriate control for subsequent interpretation of the obtained results was chosen. We analysed three widely used control groups (non-glioma cells) in glioblastoma research: Human Dermal Fibroblasts (HDFa), Normal Human Astrocytes (NHA), and commercially available mRNAs extracted from healthy human brain tissues (hRNA). The gene expression profiles of individual glioblastoma cell lines may vary due to the selection of a different control group to correlate with. Moreover, we present the original multicriterial decision making (MCDM) for the possible characterization of gene expression profiles. We observed deregulation of 75 genes out of 78 tested in the A172 cell line, while T98G and SW1088 cells exhibited changes in 72 genes. By comparing the delta cycle threshold value of the tumour groups to the mean value of the three controls, only changes in the expression of 26 genes belonging to the following pathways were identified: angiogenesis FGF2; apoptosis APAF1, CFLAR, XIAP; cellular senescence BM1, ETS2, IGFBP5, IGFBP7, SOD1, TBX2; DNA damage and repair ERCC5, PPP1R15A; epithelial to mesenchymal transition SNAI3, SOX10; hypoxia ADM, ARNT, LDHA; metabolism ATP5A1, COX5A, CPT2, PFKL, UQCRFS1; telomeres and telomerase PINX1, TINF2, TNKS, and TNKS2. We identified a human astrocyte cell line and normal human brain tissue as the appropriate control group for an in vitro model, despite the small sample size. A different method of assessing gene expression levels produced the same disparities, highlighting the need for caution when interpreting the accuracy of tumorigenesis markers.<\/jats:p>","DOI":"10.3390\/ijms231810883","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T23:39:22Z","timestamp":1663544362000},"page":"10883","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells"],"prefix":"10.3390","volume":"23","author":[{"given":"Zuzana","family":"Majercikova","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161\/4D, SK-03601 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Dibdiakova","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161\/4D, SK-03601 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Gala","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Science, University of P.J. Safarik, Jesenna 5, SK-04001 Kosice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-1419","authenticated-orcid":false,"given":"Denis","family":"Horvath","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Biosciences, Technology and Innovation Park, University of P.J. Safarik, Trieda SNP 1, SK-04011 Kosice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2952-0398","authenticated-orcid":false,"given":"Radovan","family":"Murin","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161\/4D, SK-03601 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-8837","authenticated-orcid":false,"given":"Gabriel","family":"Zoldak","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Biosciences, Technology and Innovation Park, University of P.J. Safarik, Trieda SNP 1, SK-04011 Kosice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Hatok","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161\/4D, SK-03601 Martin, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer"},{"key":"ref_6","first-page":"1410","article-title":"Molecular biology of glioblastoma: Classification and mutational locations","volume":"67","author":"Soomro","year":"2017","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_7","first-page":"vdac002","article-title":"Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma","volume":"4","author":"Yang","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2014.9.FOCUS14521","article-title":"Molecular and cellular heterogeneity: The hallmark of glioblastoma","volume":"37","author":"Aum","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4149\/gpb_2014007","article-title":"Most frequent molecular and immunohistochemical markers present in selected types of brain tumors","volume":"33","author":"Kolarovszki","year":"2014","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/neuonc\/noy132","article-title":"MGMT promoter methylation status testing to guide therapy for glioblastoma: Refining the approach based on emerging evidence and current challenges","volume":"21","author":"Mansouri","year":"2019","journal-title":"Neuro-Oncology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhou, W., and Wahl, D.R. (2019). Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance. Cancers, 11.","DOI":"10.3390\/cancers11091231"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12272","DOI":"10.1038\/s41598-020-68473-6","article-title":"Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-Z","article-title":"Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses","volume":"18","author":"Weller","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_14","first-page":"349","article-title":"Characteristics of A172 and T98G cell lines","volume":"58","author":"Kiseleva","year":"2016","journal-title":"Tsitologiia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ejca.2013.01.002","article-title":"Gene expression changes associated with erlotinib response in glioma cell lines","volume":"49","author":"Lorente","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lee, S.Y., Slagle-Webb, B., Rizk, E., Patel, A., Miller, P.A., Sung, S.S., and Connor, J.R. (2014). Characterization of a novel anti-cancer compound for astrocytomas. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108166"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Menezes, W.P., Silva, V., Gomes, I., Rosa, M.N., Spina, M., Carloni, A.C., Alves, A., Melendez, M., Almeida, G.C., and Silva, L. (2020). Loss of 5\u2032-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, It Is Not Associated with Higher Tumor Aggressiveness. Cells, 9.","DOI":"10.3390\/cells9020492"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3892\/or.2016.5191","article-title":"Microfluidic profiling of apoptosis-related genes after treatment with BH3-mimetic agents in astrocyte and glioblastoma cell lines","volume":"36","author":"Vidomanova","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"351908","DOI":"10.1155\/2010\/351908","article-title":"Molecular therapeutic targets for glioma angiogenesis","volume":"2010","author":"Takano","year":"2010","journal-title":"J. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/glia.440150313","article-title":"Angiogenesis in malignant gliomas","volume":"15","author":"Plate","year":"1995","journal-title":"Glia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21468","DOI":"10.18632\/oncotarget.4097","article-title":"Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-\u03b22 and Ran GTPase in human glioblastoma cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3892\/or.2014.3283","article-title":"Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma","volume":"32","author":"Ohashi","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.12.003","article-title":"The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture","volume":"346","author":"Haley","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.87.15.5710","article-title":"Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues","volume":"87","author":"Takahashi","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: From pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fonc.2014.00197","article-title":"X-linked inhibitor of apoptosis protein\u2014A critical death resistance regulator and therapeutic target for personalized cancer therapy","volume":"4","author":"Obexer","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.7150\/jca.28229","article-title":"Prognostic Value of XIAP Level in Patients with Various Cancers: A Systematic Review and Meta-Analysis","volume":"10","author":"Gao","year":"2019","journal-title":"J. Cancer"},{"key":"ref_29","first-page":"919","article-title":"Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis","volume":"30","author":"Mizutani","year":"2007","journal-title":"Int. J. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1038\/cddis.2013.157","article-title":"Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: A systems medicine approach","volume":"4","author":"Murphy","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1095\/biolreprod.105.045146","article-title":"Influence of TRP53 status on FAS membrane localization, CFLAR (c-FLIP) ubiquitinylation, and sensitivity of GC-2spd (ts) cells to undergo FAS-mediated apoptosis","volume":"74","author":"Chandrasekaran","year":"2006","journal-title":"Biol. Reprod."},{"key":"ref_32","first-page":"675","article-title":"Identification of novel hypoxia response genes in human glioma cell line a172","volume":"16","author":"Baghbani","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_33","first-page":"vdaa151","article-title":"Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma","volume":"2","author":"Brahm","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1038\/s41418-020-0545-9","article-title":"The apoptosome molecular timer synergises with XIAP to suppress apoptosis execution and contributes to prognosticating survival in colorectal cancer","volume":"27","author":"Fullstone","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.1327","article-title":"Over-expression of APAF-1 and caspase-9 augments radiation-induced apoptosis in U-373MG glioma cells","volume":"93","author":"Shinoura","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3892\/ijmm.2015.2369","article-title":"Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme","volume":"36","author":"Blahovcova","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Vitovcova, B., Skarkova, V., Rudolf, K., and Rudolf, E. (2020). Biology of Glioblastoma Multiforme-Exploration of Mitotic Catastrophe as a Potential Treatment Modality. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155324"},{"key":"ref_38","first-page":"315","article-title":"Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma","volume":"52","author":"Mateoiu","year":"2011","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_39","first-page":"797","article-title":"Extracellular matrix differences in glioblastoma patients with different prognoses","volume":"17","author":"Virga","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13241","DOI":"10.18632\/oncotarget.3676","article-title":"CDC20 maintains tumor initiating cells","volume":"6","author":"Xie","year":"2015","journal-title":"Oncotarget"},{"key":"ref_41","first-page":"714","article-title":"Stathmin expression in glioma-derived microvascular endothelial cells: A novel therapeutic target","volume":"27","author":"Dong","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/bjc.2014.427","article-title":"The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer","volume":"111","author":"Hemdan","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1007\/s13277-015-3361-y","article-title":"Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","article-title":"A WEE1 family business: Regulation of mitosis, cancer progression, and therapeutic target","volume":"13","author":"Cerchione","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1158\/1535-7163.MCT-15-0692","article-title":"Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma","volume":"15","author":"Lescarbeau","year":"2016","journal-title":"Mol. Cancer. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0973-1482.165861","article-title":"Tumour suppressive effects of WEE1 gene silencing in neuroblastomas","volume":"12","author":"Tashnizi","year":"2016","journal-title":"J. Cancer Res. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1056154","article-title":"Human DNA repair genes","volume":"291","author":"Wood","year":"2001","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mrrev.2014.11.002","article-title":"Oxidatively induced DNA damage and its repair in cancer","volume":"763","author":"Dizdaroglu","year":"2015","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"36867","DOI":"10.18632\/oncotarget.26409","article-title":"Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent","volume":"9","author":"Toma","year":"2018","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e6832","DOI":"10.1097\/MD.0000000000006832","article-title":"Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies","volume":"96","author":"Qian","year":"2017","journal-title":"Medicine"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"De Vleeschouwer, S. (2017). Molecular Mechanisms of Glioma Cell Motility. Glioblastoma, Codon Publication. Chapter 5.","DOI":"10.15586\/codon.glioblastoma.2017"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3892\/ol.2016.4113","article-title":"Epithelial-mesenchymal transition in glioblastoma progression","volume":"11","author":"Iwadate","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fonc.2014.00358","article-title":"Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition","volume":"4","author":"Lindsey","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","article-title":"A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition","volume":"9","author":"Xu","year":"2015","journal-title":"Cell Adh. Migr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11060-005-5533-x","article-title":"Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas","volume":"76","author":"Bannykh","year":"2006","journal-title":"J. Neurooncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/neuonc\/noab022","article-title":"Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling","volume":"23","author":"Schaffenrath","year":"2021","journal-title":"Neuro. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/1541-7786.MCR-07-0113","article-title":"Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B-induced gliomagenesis","volume":"5","author":"Ferletta","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","article-title":"Hypoxia: A key regulator of angiogenesis in cancer","volume":"26","author":"Liao","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_60","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.bjc.6600830","article-title":"Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour","volume":"88","author":"Tanaka","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11060-006-9314-y","article-title":"CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas","volume":"83","author":"Lesniak","year":"2007","journal-title":"J. Neurooncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: A cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/cam.26345","article-title":"How does cancer cell metabolism affect tumor migration and invasion?","volume":"7","author":"Han","year":"2013","journal-title":"Cell Adh. Migr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/WNR.0000000000000506","article-title":"Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma","volume":"27","author":"Li","year":"2016","journal-title":"Neuroreport"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12823","DOI":"10.1073\/pnas.1413933111","article-title":"Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients","volume":"111","author":"Crane","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/neuonc\/now024","article-title":"Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation","volume":"18","author":"Schulte","year":"2016","journal-title":"Neuro Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/neuonc\/not243","article-title":"Lactate dehydrogenase A silencing in IDH mutant gliomas","volume":"16","author":"Chesnelong","year":"2014","journal-title":"Neuro-Oncology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Sanzey, M., Abdul Rahim, S.A., Oudin, A., Dirkse, A., Kaoma, T., Vallar, L., Herold-Mende, C., Bjerkvig, R., Golebiewska, A., and Niclou, S.P. (2015). Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123544"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"752404","DOI":"10.3389\/fmolb.2021.752404","article-title":"High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower Survival","volume":"8","author":"Stanke","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41467-017-00906-9","article-title":"Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00401-013-1173-y","article-title":"Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells","volume":"126","author":"Kathagen","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11060-018-2911-8","article-title":"G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity","volume":"139","author":"Yang","year":"2018","journal-title":"J. Neurooncol."},{"key":"ref_75","first-page":"6952","article-title":"PinX1 is up-regulated and associated with poor patients\u2019 survival in gliomas","volume":"8","author":"Bai","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3960","article-title":"Forging a signature of in vivo senescence","volume":"15","author":"Sharpless","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_77","first-page":"1000151","article-title":"Aberrant expression of ETS1 and ETS2 proteins in cancer","volume":"2","author":"Fry","year":"2018","journal-title":"Cancer Rep. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/neuonc\/noz190","article-title":"\u0394Np73\/ETS2 complex drives glioblastoma pathogenesis\u2014Targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma","volume":"22","author":"Cam","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Babal, Y.K., Kandemir, B., and Kurnaz, I.A. (2021). Gene Regulatory Network of ETS Domain Transcription Factors in Different Stages of Glioma. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020138"},{"key":"ref_80","first-page":"RA210-5","article-title":"Superoxide dismutase\u2014Applications and relevance to human diseases","volume":"8","author":"Noor","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.freeradbiomed.2008.08.009","article-title":"Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells","volume":"45","author":"Gao","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12935-020-01515-1","article-title":"Identification of potential biomarkers and candidate small molecule drugs in glioblastoma","volume":"20","author":"Lu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-15-0173","article-title":"The stress kinase p38a as a target for cancer therapy","volume":"75","author":"Igea","year":"2015","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/1878-0261.12810","article-title":"In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor","volume":"14","author":"Carrasco","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(00)80760-6","article-title":"Mammalian telomeres end in a large duplex loop","volume":"97","author":"Griffith","year":"1999","journal-title":"Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/emboj.2009.195","article-title":"Telomere length regulation: Coupling DNA end processing to feedback regulation of telomerase","volume":"28","author":"Shore","year":"2009","journal-title":"EMBO J."},{"key":"ref_87","first-page":"5","article-title":"Cellular senescence and cancer treatment","volume":"1775","author":"Schmitt","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0092-8674(01)00538-4","article-title":"The Pin2\/TRF1-interacting protein PinX1 is a potent telomerase inhibitor","volume":"107","author":"Zhou","year":"2001","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2867-14-46","article-title":"Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer","volume":"14","author":"Shi","year":"2014","journal-title":"Cancer Cell Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12032-015-0545-7","article-title":"PinX1 inhibits cell proliferation, migration and invasion in glioma cells","volume":"32","author":"Mei","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_91","first-page":"6720","article-title":"Amplification of PINX1 in glioblastoma promotes cell proliferation and is targeted by miR-627","volume":"10","author":"Yongjie","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/path.2023","article-title":"Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer","volume":"210","author":"Montanaro","year":"2006","journal-title":"J. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10637-019-00748-w","article-title":"Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion","volume":"37","author":"Miao","year":"2019","journal-title":"Investig. New Drugs"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/sj.emboj.7601903","article-title":"Protein requirements for sister telomere association in human cells","volume":"28","author":"Canudas","year":"2007","journal-title":"EMBO J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1248012","DOI":"10.1126\/science.1248012","article-title":"Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control","volume":"346","author":"Clevers","year":"2014","journal-title":"Science"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Paradowski, B., Shekhovtsov, A., Baczkiewicz, A., Kizielewicz, B., and Salabun, W. (2021). Similarity Analysis of Methods for Objective Determination of Weights in Multi-Criteria Decision Support Systems. Symmetry, 13.","DOI":"10.3390\/sym13101874"},{"key":"ref_99","unstructured":"Weisstein, E.W. (2022, February 02). Lehmer Mean. Available online: https:\/\/mathworld.wolfram.com\/LehmerMean.html."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Bullen, P.S. (2003). Handbook of Means and Their Inequalities, Kluwer.","DOI":"10.1007\/978-94-017-0399-4"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10883\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:33:30Z","timestamp":1760142810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":100,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms231810883"],"URL":"https:\/\/doi.org\/10.3390\/ijms231810883","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]}}}